Serum fibroblast growth factor 21 is a novel biomarker of cachexia in chronic liver disease. - Tanaka T; Suda G; Ohara M; Maehara O; Yoda T; Fu Q; Yang Z; Yasuura N; Meno A; Sasaki T; Kohya R; Kitagataya T; et al. (Frontiers in nutrition, 2026)